FYERS
Home
/
Stocks
/
Results
/
Nath Bio-Genes (India) Results

Nath Bio-Genes (India) Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-24%9%10%
-33%--3%
4%-15%-13%-13%
7%4%6%6%

Peer Comparison

Symbol
KSCL
VENKEYS
AVTNPL
FRESHARA-ST
BSHSL
REGAAL
MGEL
SHEETAL-SM
KOTYARK-BE
NATHBIOGEN
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
721₹3697 Cr14.8154.460.16₹296 Cr
1,787.2₹2403 Cr13.8635.48149.6₹139 Cr
90.13₹1384 Cr16.512.046.26₹65 Cr
485₹1143 Cr31.55—16.78₹36 Cr
88₹922 Cr32.141.362.89₹27 Cr
83.85₹884 Cr14.781.37.5₹56 Cr
15.62₹528 Cr11.170.261.51₹45 Cr
353₹410 Cr35.668.7212.47₹12 Cr
32.5₹351 Cr18.710.342.79₹19 Cr
147.78₹284 Cr7.7716.9821.37₹42 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
₹328 Cr₹52 Cr₹66 Cr₹44 Cr₹284 Cr₹52 Cr₹37 Cr₹32 Cr₹244 Cr₹43 Cr₹32 Cr₹23 Cr₹235 Cr₹45 Cr₹25 Cr₹22 Cr₹209 Cr₹27 Cr
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹4 Cr₹48 L₹8 L₹13 L₹41 L₹4 L₹6 L₹12 L₹26 L₹6 L₹20 L₹4 L₹73 L
₹330 Cr₹54 Cr₹68 Cr₹46 Cr₹285 Cr₹56 Cr₹37 Cr₹32 Cr₹244 Cr₹43 Cr₹32 Cr₹23 Cr₹235 Cr₹45 Cr₹25 Cr₹22 Cr₹209 Cr₹28 Cr
₹294 Cr₹48 Cr₹63 Cr₹39 Cr₹255 Cr₹53 Cr₹30 Cr₹28 Cr₹208 Cr₹40 Cr₹27 Cr₹18 Cr₹199 Cr₹42 Cr₹20 Cr₹18 Cr₹176 Cr₹50 Cr
₹37 Cr₹7 Cr₹5 Cr₹8 Cr₹31 Cr₹4 Cr₹9 Cr₹5 Cr₹37 Cr₹4 Cr₹6 Cr₹5 Cr₹37 Cr₹4 Cr₹6 Cr₹5 Cr₹34 Cr-₹21 Cr
₹4 Cr₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹1 Cr₹4 Cr₹3 Cr₹2 Cr₹1 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr
₹33 Cr₹2 Cr₹2 Cr₹3 Cr₹29 Cr₹2 Cr₹4 Cr₹1 Cr₹34 Cr₹2 Cr₹5 Cr₹2 Cr₹33 Cr₹2 Cr₹2 Cr₹2 Cr₹31 Cr-₹113 Cr
₹32 Cr-₹90,000₹2 Cr₹3 Cr₹28 Cr₹1 Cr₹3 Cr₹1 Cr₹33 Cr₹3 Cr₹4 Cr₹2 Cr₹33 Cr₹1 Cr₹1 Cr₹1 Cr₹31 Cr-₹116 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2013Mar 2012
——————
₹19 Cr₹19 Cr₹19 Cr₹19 Cr₹16 Cr₹16 Cr
₹625 Cr₹591 Cr₹554 Cr₹523 Cr₹41 Cr₹30 Cr
₹625 Cr₹591 Cr₹554 Cr₹523 Cr₹41 Cr₹30 Cr
₹644 Cr₹610 Cr₹573 Cr₹542 Cr₹57 Cr₹46 Cr
₹0₹0₹0-₹46,000₹0₹0
₹2 Cr₹3 Cr₹40 L₹66 L₹1 Cr₹57 L
₹11 Cr₹2 Cr₹0₹0₹18 L₹20 L
₹0₹0₹0₹0-₹90 L-₹86 L
₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹1 Cr₹1 Cr
₹17 Cr₹8 Cr₹3 Cr₹3 Cr₹2 Cr₹1 Cr
——————
₹79 Cr₹43 Cr₹28 Cr₹43 Cr₹28 Cr₹16 Cr
₹176 Cr₹113 Cr₹84 Cr₹58 Cr₹53 Cr₹47 Cr
₹108 Cr₹104 Cr₹104 Cr₹92 Cr₹17 Cr₹8 Cr
₹1 Cr₹2 Cr₹87 L₹2 Cr₹29 L₹6 L
₹365 Cr₹262 Cr₹216 Cr₹194 Cr₹98 Cr₹72 Cr
₹1026 Cr₹880 Cr₹793 Cr₹739 Cr₹157 Cr₹119 Cr
₹89 Cr₹92 Cr₹72 Cr₹61 Cr₹34 L₹25 L
₹123 Cr₹110 Cr₹105 Cr₹93 Cr₹19 Cr₹11 Cr
——————
₹279 Cr₹274 Cr₹270 Cr₹267 Cr₹77 Cr₹56 Cr
₹29 Cr₹25 Cr₹25 Cr₹22 Cr₹39 Cr₹35 Cr
₹250 Cr₹249 Cr₹244 Cr₹245 Cr₹38 Cr₹21 Cr
₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹18,475₹51 L
₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹18,475₹51 L
₹80 Cr₹53 Cr₹24 Cr₹22 Cr₹0₹2 Cr
₹336 Cr₹309 Cr₹273 Cr₹272 Cr₹38 Cr₹23 Cr
——————
₹338 Cr₹230 Cr₹208 Cr₹220 Cr₹77 Cr₹66 Cr
₹89 Cr₹94 Cr₹97 Cr₹86 Cr₹21 Cr₹12 Cr
₹89 Cr₹77 Cr₹38 Cr₹4 Cr₹2 Cr₹3 Cr
₹2 Cr₹46 L₹37 L₹39 L₹2 Cr₹46 L
₹172 Cr₹169 Cr₹176 Cr₹157 Cr₹17 Cr₹14 Cr
₹690 Cr₹572 Cr₹520 Cr₹468 Cr₹120 Cr₹96 Cr
₹325 Cr₹309 Cr₹303 Cr₹273 Cr₹22 Cr₹24 Cr
₹1026 Cr₹880 Cr₹793 Cr₹739 Cr₹157 Cr₹119 Cr
₹339₹321₹302₹285₹36₹29
₹339₹321₹302₹285₹36₹29

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2013Mar 2012
₹41 Cr₹42 Cr₹36 Cr-₹63 Cr₹12 Cr₹0
₹13 Cr₹10 Cr₹13 Cr₹102 Cr₹8 Cr₹0
-₹35 Cr₹23 Cr-₹10 Cr-₹19 Cr-₹6 Cr₹0
₹19 Cr₹75 Cr₹39 Cr₹20 Cr₹15 Cr₹0
₹18 Cr₹75 Cr₹38 Cr₹17 Cr₹14 Cr₹0
-₹4 Cr-₹27 Cr-₹3 Cr-₹20 Cr-₹21 Cr₹0
-₹2 Cr-₹8 Cr-₹2 Cr-₹22 Cr₹6 Cr₹0
₹11 Cr₹39 Cr₹34 Cr-₹25 Cr-₹81 L₹0
₹77 Cr₹38 Cr₹4 Cr₹29 Cr₹3 Cr₹0
₹89 Cr₹77 Cr₹38 Cr₹4 Cr₹2 Cr₹0

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)150.95
Volume (₹)29,647.00
High (₹)150.95
Upper Circuit180.61
Low (₹)141.30
Lower Circuit120.41
Prev Close152.51
52W High (₹)204.00
Price147.78
52W Low (₹)126.15

Share Market Cap & Key Ratios Overview

M.Cap (₹)284.39 Cr
Div. Yield (%)1.34
PE Ratio7.77
Debt to Equity0.19
Price to Book0.43
Book Value339.08
EPS (TTM)19.26
Face Value10.00
ROE (%)6.15

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
KSCLNSE
VENKEYSNSE
AVTNPLNSE
FRESHARA-STNSE
BSHSLNSE
REGAALNSE
MGELNSE
SHEETAL-SMNSE
KOTYARK-BENSE
NATHBIOGENNSE
LTP
1W Low
1W High
Market cap (₹)
721-11.3 (-1.54%)
706.05
749.85
3,697Cr
1787.2+138.9 (8.43%)
1631.60
1795
2,403Cr
90.13+0.03 (0.03%)
87.71
93.33
1,384Cr
485+54 (12.53%)
427
493.95
1,143Cr
88-4.51 (-4.88%)
85.41
93.90
922Cr
83.85-4.31 (-4.89%)
82.30
89.28
884Cr
15.62-0.1 (-0.64%)
13
17.08
528Cr
353+13 (3.82%)
340
353
410Cr
32.5-0.39 (-1.19%)
30.56
34.58
351Cr
147.78-4.87 (-3.19%)
141.30
154
284Cr

Nath Bio-Genes (India) Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹37.05Cr; with other income of ₹1.9Cr, profit before interest and tax came to ₹37.25Cr. Interest expense was ₹4.26Cr; PBT before exceptional items stood at ₹32.98Cr. Cost mix (full year): raw materials ₹12.73Cr; employee cost ₹31.83Cr; depreciation ₹1Cr; other expenses ₹293.25Cr. Basis: consolidated annual results.

Nath Bio-Genes (India) Ltd Quaterly Results Key Takeaways

Nath Bio-Genes (India) Ltd reported ₹328.4Cr total income from operations in Jun 2026, softer than ₹51.59Cr in Mar 2026 but higher than ₹283.7Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹37.05Cr; with other income of ₹1.9Cr, profit before interest and tax came to ₹37.25Cr. Interest expense was ₹4.26Cr, taking profit before tax to ₹32.98Cr. After tax of ₹72.1Lakh, profit after tax stood at ₹32.26Cr (vs ₹-90000 cr in Mar 2026 and ₹28.28Cr in Jun 2025).